In the annexin V/7AAD assay, after 48 h of drug treatment (Figure 3A), UVC/sinularin in oral cancer Ca9-22 and CAL 27 cells demonstrated higher annexin V (+) (%) than the separate treatments and control (Figure 3B). This evidence concerns the gene ANXA5 and lip and oral cavity carcinoma.